Back to all bills
S 755119th CongressIntroduced
Finn Sawyer Access to Cancer Testing Act
Introduced: Oct 28, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Finn Sawyer Access to Cancer Testing Act aims to improve access to advanced cancer diagnostic and laboratory tests for Medicare, Medicaid, and CHIP beneficiaries by establishing coverage, payment mechanisms, and educational programs.
Key Points
- 1Establishes Medicare coverage for next-generation sequencing and molecular diagnostic tests for cancer patients
- 2Requires Medicaid and CHIP programs to include coverage of cancer diagnostic and laboratory tests
- 3Sets payment rates at 80% of the lesser of actual charge or clinical diagnostic lab test rate
- 4Mandates an education and awareness program on genomic testing for physicians and the public
- 5Includes frequency limitations and exclusions for unnecessary repeat testing
- 6Effective dates vary by program, with most provisions starting January 1, 2027
Impact Areas
Cancer patients and survivorsHealthcare providers and laboratoriesMedicare beneficiariesMedicaid recipientsChildren's Health Insurance Program enrollees
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025